Neuro-Cognitive Rehabilitation of Attention Disorders in Depressed Patient by TMS

Zarghi A^1, , Zali A¹, Ashrafi F¹, Elyaspour D² and Moazezi S¹

¹Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

²Shohada hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Cite this paper

Zarghi A, Zali A, Ashrafi F, Elyaspour D and Moazezi S. Neuro-Cognitive Rehabilitation of Attention Disorders in Depressed Patient by TMS. American Journal of Medical Case Reports. 2014; 2(1):23-26. doi: 10.12691/AJMCR-2-1-8

Abstract

Introduction: The aim of this study was to evaluate the application of this tool in the neurocognitive rehabilitation of depressed patients. Case presentation: This study was done on a 41 years-old Iranian woman who presented distraction associated with depression. We evaluated her during 6 weeks since 2012. 5. 22 until 2012. 7. 7 in Functional Neurosurgery Research Center of Shohada Hospital, Tehran, Iran. Before entering the study it was necessary for the patient to give informed consent. She had to be examined first by psychiatrist, neurologist and later by cognitive neuroscientist for neurocognitive assessments. We evaluated attention measure through STROOP and CPT tasks and mental evaluations were implemented by using MMSE, Beck depression questionnaires before and after TMS. Based on the performance assessment of the patient before and after TMS, a difference was observed between measures of tasks and questionnaires. Conclusions: Cognitive and mental impairments could be improved by TMS.

Keywords

neuro-cognitive rehabilitation, attention, depression, TMS

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Beck AT, Ward CH, Mendelson M, Mock J, Eraugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 61-571.
[2]	Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012; 29: 587-96.
[3]	Demirtas-Tatlidede A, Vahabzadeh-Hagh A, Pascual-Leone A. Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology. 2013; 64: 566-78.
[4]	Dukakis K, Tye L. Shock: The healing power of electroconvulsive therapy. New York: Aver. 2006.
[5]	Fink M, Taylor MA. Electroconvulsive therapy. Evidence and challenges. Journal of the American Medical Association. 2007; 298 (3); 330-332.
[6]	Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind placebo-controlled trial. Archives of General Psychiatry. 2003; 60 (10); 1002-1008.
[7]	Folstein M, Folstein SE, McHugh PR. “Mini-Mental State” a Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research. 1975; 12 (3); 189-198.
[8]	George MS, Sackeim HA, Rush AH, Marangell LB, Nahas Z, Husain MM, Lisanby S, Burt T, Goldman J, Ballenger JC. Vagus nerve stimulation: a new tool for brain research and therapy. Biological Psychiatry. 2000; 47 (4); 287-295.
[9]	Janicak PG, O-Reardon JP, Sampson SM, Husain MM, Lisanby SH, Rado JT, Heart KL, Demitrack MA. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. Journal of Clinical Psychiatry. 2008; 69 (2); 222-232.
[10]	Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Berstein HJ, O-Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from CORE. Archives of General Psychiatry. 2006; 63 (12); 1337-1344.
[11]	Kito S. Treatment of depression using transcranial stimulation (TMS) and neuroimaging. Seishin Shinkeigaku Zasshi. 2012; 114 (5); 601-7.
[12]	Lisanby SH, Luber B, Schaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology. 2003; 28 (10); 1852-1865.
[13]	Loo CK, Mitchell PB, Croker VM, Malhi GS, Wen W, Gandevia SC, Sachdev PS. Double-blind controlled investigation of bilateral prefrontal transcranial magnetic stimulation for the treatment of resistant major depression. Psychological Medicine. 2003; 33 (1); 33-40.
[14]	Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Klulisevsky J, Gironell A. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev.2: CD 003493. 2002.
[15]	Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007; 32 (1); 244-254.
[16]	Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F, Doroodgar S, Khodadadi SM. The Relationship between Age, Sex and Education Variables with Selective, Sustained Attention and Planning through Cognitive Tasks among Healthy Adults. Basic and Clinical Neuroscience. 2011; 2 (3); 58-67.
[17]	Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F, Khodadadi M. Comparative assessment of neuro-cognitive impairments among patients with brain tumor and healthy adults. Turkish Neurosurgery. 2012; 22 (3); 309-316.
[18]	Zarghi A, Zali A, Tehranidost M, Ashrafi F, Zarindast MR, Moazezi M, Khodadadi SM. Assessment of Selective Attention With CSCWT (Computerized Stroop Color-Word Test) Among Children and Adults. US-China Education Review A 1 2012; 121-127.